Event
Collaborating to Advance Health Equity for Diabetes and Chronic Kidney Disease - M-CERSI Conference
Wednesday, February 10, 2021
10:00 a.m.-3:00 p.m.
Virtual
Ann Anonsen
cersi@umd.edu
Webex event recording: Collaborating to Advance Health Equity in Diabetes and Chronic Kidney Disease
________________________________________________________________
Scheduled for Wednesday, February 10, 2021, "Collaborating to Advance Health Equity for Diabetes and Chronic Kidney Disease" will bring together researchers, patients, policy makers, and clinicians from across academia, government, and industry to advance our understanding of the following:
-
Leveraging patient experience data and community/system approaches to inform care, drug development and overall research agenda to improve patient outcomes and reduce health inequities for diverse communities with diabetes and chronic kidney disease (CKD).
-
Explore barriers to diversity in clinical trials for CKD and diabetes and strategies to improve diversity in clinical trials.
-
Utilization of real-world data to inform strategies and decision making on the management of diabetes and CKD.
The event will take place from 10 am -3:05 pm EST via webinar (please register to receive web link to event).
About the Event:
The workshop will be open to public.
Regulatory Impact:
This workshop supports the Office of Minority Health and Health Equity's (OMHHE) mission, the 21st Century Cures Act to understand patient perspectives, and the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA section 907), an effort to advance inclusion of racial and ethnic minority populations in clinical trials.
Visit this page for more event information including an agenda
This workshop is supported by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award U01FD005946 totaling $5,000 with 100 percent funded by FDA/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by FDA/HHS, or the U.S. Government.
